Zoledronic Acid Potentiates mTOR Inhibition and Abolishes the Resistance of Osteosarcoma Cells to RAD001 (Everolimus): Pivotal Role of the Prenylation Process

Moriceau, G., Ory, B., Mitrofan, L. et al. (11 more authors) (2010) Zoledronic Acid Potentiates mTOR Inhibition and Abolishes the Resistance of Osteosarcoma Cells to RAD001 (Everolimus): Pivotal Role of the Prenylation Process. Cancer Research, 70 (24). pp. 10329-10339. ISSN 0008-5472

Abstract

Metadata

Authors/Creators:
  • Moriceau, G.
  • Ory, B.
  • Mitrofan, L.
  • Riganti, C.
  • Blanchard, F.
  • Brion, R.
  • Charrier, C.
  • Battaglia, S.
  • Pilet, P.
  • Denis, M.G.
  • Shultz, L.D.
  • Monkkonen, J.
  • Redini, F.
  • Heymann, D. ORCID logo https://orcid.org/0000-0001-7777-0669
Copyright, Publisher and Additional Information: © 2010 American Association for Cancer Research
Keywords: osteosarcoma; mTOR; rapamycin; bisphosphonate; drug resistance
Dates:
  • Published: 15 December 2010
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 18 May 2016 15:34
Last Modified: 11 Apr 2017 04:43
Published Version: http://dx.doi.org/10.1158/0008-5472.CAN-10-0578
Status: Published
Publisher: American Association for Cancer Research
Identification Number: https://doi.org/10.1158/0008-5472.CAN-10-0578
Related URLs:

Share / Export

Statistics